Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Provention Bio 6.25M share Secondary priced at $16.00 » 20:05
01/13/21
01/13
20:05
01/13/21
20:05
PRVB

Provention Bio

$16.68 /

-2.8 (-14.37%)

The deal size was…

The deal size was increased to 6.25M shares of common stock form 6M shares of common stock. SVB Leerink and Cantor Fitzgerald acted as joint book running managers for the offering.

ShowHide Related Items >><<
PRVB Provention Bio
$16.68 /

-2.8 (-14.37%)

PRVB Provention Bio
$16.68 /

-2.8 (-14.37%)

01/04/21 Chardan
Provention Bio price target raised to $40 from $35 at Chardan
11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
PRVB Provention Bio
$16.68 /

-2.8 (-14.37%)

  • 14
    Jan
  • 18
    Jun
PRVB Provention Bio
$16.68 /

-2.8 (-14.37%)

Tuesday
On The Fly
Fly Intel: After-Hours Movers » 18:32
01/12/21
01/12
18:32
01/12/21
18:32
MTRX

Matrix Service

$12.24 /

+0.59 (+5.06%)

, STIM

Neuronetics

$11.69 /

-0.36 (-2.99%)

, FARM

Farmer Bros.

$5.10 /

+0.39 (+8.28%)

, DMTK

DermTech

$37.00 /

+3.61 (+10.81%)

, ALLY

Ally Financial

$38.38 /

+0.88 (+2.35%)

, GTLS

Chart Industries

$136.85 /

+6.3699 (+4.88%)

, REGN

Regeneron

$505.94 /

+2.45 (+0.49%)

, EXFO

Exfo

$3.50 /

+0.2 (+6.06%)

, BBCP

Concrete Pumping

$4.53 /

+0.33 (+7.86%)

, PRTY

Party City

$8.08 /

+0.235 (+3.00%)

, FWP

Forward Pharma

$7.78 /

-0.19 (-2.38%)

, PRVB

Provention Bio

$19.48 /

+1.53 (+8.52%)

, URBN

Urban Outfitters

$30.31 /

+1.65 (+5.76%)

, MARA

Marathon Patent Group

$26.13 /

+2.72 (+11.62%)

Check out this evening's…

ShowHide Related Items >><<
URBN Urban Outfitters
$30.31 /

+1.65 (+5.76%)

STIM Neuronetics
$11.69 /

-0.36 (-2.99%)

REGN Regeneron
$505.94 /

+2.45 (+0.49%)

PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

PRTY Party City
$8.08 /

+0.235 (+3.00%)

MARA Marathon Patent Group
$26.13 /

+2.72 (+11.62%)

GTLS Chart Industries
$136.85 /

+6.3699 (+4.88%)

FWP Forward Pharma
$7.78 /

-0.19 (-2.38%)

FARM Farmer Bros.
$5.10 /

+0.39 (+8.28%)

EXFO Exfo
$3.50 /

+0.2 (+6.06%)

DMTK DermTech
$37.00 /

+3.61 (+10.81%)

ALLY Ally Financial
$38.38 /

+0.88 (+2.35%)

MTRX Matrix Service
$12.24 /

+0.59 (+5.06%)

02/24/20 Jefferies
Epizyme, Blueprint among cancer companies that fit M&A criteria, says Jefferies
02/19/20
Fly Intel: Top five analyst upgrades
02/19/20 Sidoti
Matrix Service upgraded to Buy following 28% pullback at Sidoti
02/19/20 Sidoti
Matrix Service upgraded to Buy from Neutral at Sidoti
STIM Neuronetics
$11.69 /

-0.36 (-2.99%)

01/08/21 JMP Securities
Neuronetics price target raised to $15 from $10 at JMP Securities
12/07/20 BTIG
Neuronetics price target raised to $14 from $10 at BTIG
11/23/20 Piper Sandler
Neuronetics price target raised to $9 from $7 at Piper Sandler
10/26/20 Canaccord
Neuronetics price target raised to $8 from $4 at Canaccord
FARM Farmer Bros.
$5.10 /

+0.39 (+8.28%)

01/08/21 B. Riley Securities
Farmer Bros. price target raised to $4.50 from $4 at B. Riley Securities
11/02/20 B. Riley Securities
Farmer Bros. price target lowered to $4 from $7 at B. Riley Securities
03/31/20 B. Riley Securities
Farmer Bros. price target lowered to $8 from $12 at B. Riley FBR
DMTK DermTech
$37.00 /

+3.61 (+10.81%)

01/12/21 Lake Street
DermTech price target raised to $52 from $24 at Lake Street
12/14/20 Craig-Hallum
Craig-Hallum bullish on DermTech, initiates with a Buy
12/14/20 Craig-Hallum
DermTech initiated with a Buy at Craig-Hallum
10/29/20 William Blair
DermTech initiated with an Outperform at William Blair
ALLY Ally Financial
$38.38 /

+0.88 (+2.35%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Barclays
Ally Financial upgraded to Overweight with $48 target at Barclays
01/04/21 Barclays
Ally Financial upgraded to Overweight from Equal Weight at Barclays
12/21/20
Fly Intel: Top five analyst initiations
GTLS Chart Industries
$136.85 /

+6.3699 (+4.88%)

01/06/21 Northland
Chart Industries price target raised to $137 from $104 at Northland
12/31/20 Credit Suisse
Chart Industries price target raised to $128 from $109 at Credit Suisse
12/16/20 Lake Street
Chart Industries price target raised to $134 from $111 at Lake Street
12/16/20 Craig-Hallum
Chart Industries price target raised to $147 from $107 at Craig-Hallum
REGN Regeneron
$505.94 /

+2.45 (+0.49%)

01/08/21 Citi
Regeneron upgraded to Buy from Neutral at Citi
12/30/20 Goldman Sachs
Regeneron cocktail shows first signal in hospitalized patients, says Goldman
12/10/20 Piper Sandler
Piper says AbbVie data on Rinvoq versus Dupixent 'about as expected'
11/30/20 Morgan Stanley
AbbVie price target raised to $120 from $108 at Morgan Stanley
EXFO Exfo
$3.50 /

+0.2 (+6.06%)

07/09/20 B. Riley Securities
EXFO results positive for Viavi and Dasan, says B. Riley FBR
BBCP Concrete Pumping
$4.53 /

+0.33 (+7.86%)

01/07/21 B. Riley Securities
Concrete Pumping price target raised to $6.75 from $6.50 at B. Riley Securities
01/05/21 Baird
Concrete Pumping upgraded to Outperform from Neutral at Baird
12/14/20 DA Davidson
Concrete Pumping upgraded to Buy from Neutral at DA Davidson
09/10/20 B. Riley Securities
Concrete Pumping upgraded to Buy with $6.50 target at B. Riley FBR
PRTY Party City
$8.08 /

+0.235 (+3.00%)

12/09/20 Stephens
Party City price target raised to $5 at Stephens after sale of international ops
03/13/20 Stephens
Party City downgraded to Equal Weight from Overweight at Stephens
FWP Forward Pharma
$7.78 /

-0.19 (-2.38%)

PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

01/04/21 Chardan
Provention Bio price target raised to $40 from $35 at Chardan
11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
URBN Urban Outfitters
$30.31 /

+1.65 (+5.76%)

01/06/21 Jefferies
Jefferies sees highest odds of positive pre-announcements from Boot Barn, Urban
12/17/20 UBS
Urban Outfitters price target raised to $27 from $23 at UBS
11/24/20 BMO Capital
Urban Outfitters price target raised to $29 from $21 at BMO Capital
MARA Marathon Patent Group
$26.13 /

+2.72 (+11.62%)

11/23/20 H.C. Wainwright
Marathon Patent Group initiated with a Buy at H.C. Wainwright
URBN Urban Outfitters
$30.31 /

+1.65 (+5.76%)

STIM Neuronetics
$11.69 /

-0.36 (-2.99%)

REGN Regeneron
$505.94 /

+2.45 (+0.49%)

PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

PRTY Party City
$8.08 /

+0.235 (+3.00%)

MTRX Matrix Service
$12.24 /

+0.59 (+5.06%)

MARA Marathon Patent Group
$26.13 /

+2.72 (+11.62%)

GTLS Chart Industries
$136.85 /

+6.3699 (+4.88%)

FARM Farmer Bros.
$5.10 /

+0.39 (+8.28%)

EXFO Exfo
$3.50 /

+0.2 (+6.06%)

DMTK DermTech
$37.00 /

+3.61 (+10.81%)

BBCP Concrete Pumping
$4.53 /

+0.33 (+7.86%)

ALLY Ally Financial
$38.38 /

+0.88 (+2.35%)

  • 14
    Jan
  • 07
    Jan
  • 24
    Jul
  • 18
    Jun
  • 27
    May
URBN Urban Outfitters
$30.31 /

+1.65 (+5.76%)

REGN Regeneron
$505.94 /

+2.45 (+0.49%)

URBN Urban Outfitters
$30.31 /

+1.65 (+5.76%)

STIM Neuronetics
$11.69 /

-0.36 (-2.99%)

REGN Regeneron
$505.94 /

+2.45 (+0.49%)

PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

PRTY Party City
$8.08 /

+0.235 (+3.00%)

MARA Marathon Patent Group
$26.13 /

+2.72 (+11.62%)

FARM Farmer Bros.
$5.10 /

+0.39 (+8.28%)

EXFO Exfo
$3.50 /

+0.2 (+6.06%)

DMTK DermTech
$37.00 /

+3.61 (+10.81%)

BBCP Concrete Pumping
$4.53 /

+0.33 (+7.86%)

ALLY Ally Financial
$38.38 /

+0.88 (+2.35%)

URBN Urban Outfitters
$30.31 /

+1.65 (+5.76%)

STIM Neuronetics
$11.69 /

-0.36 (-2.99%)

REGN Regeneron
$505.94 /

+2.45 (+0.49%)

PRTY Party City
$8.08 /

+0.235 (+3.00%)

MARA Marathon Patent Group
$26.13 /

+2.72 (+11.62%)

DMTK DermTech
$37.00 /

+3.61 (+10.81%)

ALLY Ally Financial
$38.38 /

+0.88 (+2.35%)

Syndicate
Provention Bio announces offering of 6M shares of common stock » 16:28
01/12/21
01/12
16:28
01/12/21
16:28
PRVB

Provention Bio

$19.48 /

+1.53 (+8.52%)

SVB Leerink and Cantor…

SVB Leerink and Cantor Fitzgerald & Co. are acting as joint bookrunning managers for the public offering. Provention Bio intends to use its net proceeds from the public offering for (i) pre-commercial activities, potential commercial activities, potential milestone or royalty payments, clinical development, and regulatory and manufacturing activities for PRV-031; (ii) development activities for PRV-015, PRV-101, and PRV-3279; (iii) the potential acquisition or in-licensing of other product candidates; and (iv) for other general corporate purposes.

ShowHide Related Items >><<
PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

01/04/21 Chardan
Provention Bio price target raised to $40 from $35 at Chardan
11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

  • 18
    Jun
PRVB Provention Bio
$19.48 /

+1.53 (+8.52%)

Syndicate
Provention Bio files automatic mixed securities shelf  16:12
01/12/21
01/12
16:12
01/12/21
16:12
PRVB

Provention Bio

$19.45 /

+1.5 (+8.36%)

 
ShowHide Related Items >><<
PRVB Provention Bio
$19.45 /

+1.5 (+8.36%)

PRVB Provention Bio
$19.45 /

+1.5 (+8.36%)

01/04/21 Chardan
Provention Bio price target raised to $40 from $35 at Chardan
11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
PRVB Provention Bio
$19.45 /

+1.5 (+8.36%)

  • 18
    Jun
PRVB Provention Bio
$19.45 /

+1.5 (+8.36%)

Over a week ago
Recommendations
Provention Bio price target raised to $40 from $35 at Chardan » 13:06
01/04/21
01/04
13:06
01/04/21
13:06
PRVB

Provention Bio

$17.60 /

+0.685 (+4.05%)

Chardan analyst Gbola…

Chardan analyst Gbola Amusa raised the firm's price target on Provention Bio to $40 from $35 and keeps a Buy rating on the shares after the company announced FDA acceptance of the Biologics License Application filing of teplizumab for the delay or prevention of clinical type 1 diabetes in at-risk individuals. The analyst sees today's news an "incremental positive," noting the "key gating factor" for teplizumab approval has been addressed with the completion of manufacturing-related issues. Amusa increased the launch probability to 90% from 80%.

ShowHide Related Items >><<
PRVB Provention Bio
$17.60 /

+0.685 (+4.05%)

PRVB Provention Bio
$17.60 /

+0.685 (+4.05%)

11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
PRVB Provention Bio
$17.60 /

+0.685 (+4.05%)

  • 18
    Jun
PRVB Provention Bio
$17.60 /

+0.685 (+4.05%)

Hot Stocks
Provention Bio: FDA files BLA, Priority Review for teplizumab » 07:08
01/04/21
01/04
07:08
01/04/21
07:08
PRVB

Provention Bio

$16.91 /

-0.35 (-2.03%)

Provention Bio announced…

Provention Bio announced that the Biologics License Application for teplizumab for the delay or prevention of clinical type 1 diabetes in at-risk individuals has been filed by the U.S. FDA. The FDA also granted Provention's request for Priority Review and assigned a user fee goal date of July 2, 2021, under the Prescription Drug User-Fee Act.

ShowHide Related Items >><<
PRVB Provention Bio
$16.91 /

-0.35 (-2.03%)

PRVB Provention Bio
$16.91 /

-0.35 (-2.03%)

11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
PRVB Provention Bio
$16.91 /

-0.35 (-2.03%)

  • 18
    Jun
PRVB Provention Bio
$16.91 /

-0.35 (-2.03%)

Hot Stocks
Provention Bio added to Nasdaq Biotechnology Index » 07:34
12/21/20
12/21
07:34
12/21/20
07:34
PRVB

Provention Bio

$17.56 /

-0.96 (-5.18%)

Provention Bio announced…

Provention Bio announced that it has been added to the NASDAQ Biotechnology Index effective prior to market open on December 21.

ShowHide Related Items >><<
PRVB Provention Bio
$17.56 /

-0.96 (-5.18%)

PRVB Provention Bio
$17.56 /

-0.96 (-5.18%)

11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
PRVB Provention Bio
$17.56 /

-0.96 (-5.18%)

  • 18
    Jun
PRVB Provention Bio
$17.56 /

-0.96 (-5.18%)

Over a month ago
Hot Stocks
Provention Bio initiates study of PRV-101 » 07:33
12/15/20
12/15
07:33
12/15/20
07:33
PRVB

Provention Bio

$18.60 /

+0.58 (+3.22%)

Provention Bio announced…

Provention Bio announced the initiation of PROVENT, a first-in-human study of its polyvalent inactivated coxsackievirus B vaccine candidate, PRV-101. Provention is developing PRV-101 for the prevention of acute CVB infection and the potential delay or prevention of type 1 diabetes and celiac disease. Results of PROVENT are expected in the second half of 2021.

ShowHide Related Items >><<
PRVB Provention Bio
$18.60 /

+0.58 (+3.22%)

PRVB Provention Bio
$18.60 /

+0.58 (+3.22%)

11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
PRVB Provention Bio
$18.60 /

+0.58 (+3.22%)

  • 18
    Jun
PRVB Provention Bio
$18.60 /

+0.58 (+3.22%)

Conference/Events
Provention Bio management to meet virtually with Cantor Fitzgerald » 04:55
12/10/20
12/10
04:55
12/10/20
04:55
PRVB

Provention Bio

$16.57 /

-0.15 (-0.90%)

Virtual Meeting to be…

Virtual Meeting to be held on December 10 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
PRVB Provention Bio
$16.57 /

-0.15 (-0.90%)

PRVB Provention Bio
$16.57 /

-0.15 (-0.90%)

11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
PRVB Provention Bio
$16.57 /

-0.15 (-0.90%)

  • 18
    Jun
PRVB Provention Bio
$16.57 /

-0.15 (-0.90%)

Conference/Events
Provention Bio management to meet virtually with Cantor Fitzgerald » 10:24
12/09/20
12/09
10:24
12/09/20
10:24
PRVB

Provention Bio

$16.50 /

-0.22 (-1.32%)

Virtual Meeting to be…

Virtual Meeting to be held on December 10 hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
PRVB Provention Bio
$16.50 /

-0.22 (-1.32%)

PRVB Provention Bio
$16.50 /

-0.22 (-1.32%)

11/02/20 Chardan
Provention Bio remains top pick for 2020 at Chardan
06/16/20 H.C. Wainwright
Provention Bio price target raised to $26 from $20 at H.C. Wainwright
06/04/20
Fly Intel: Top five analyst initiations
06/04/20 RBC Capital
Provention Bio initiated with an Outperform at RBC Capital
PRVB Provention Bio
$16.50 /

-0.22 (-1.32%)

  • 18
    Jun
PRVB Provention Bio
$16.50 /

-0.22 (-1.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.